Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial
Aston University · Universidade Federal do Rio Grande do Sul · +3 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
856
total citations
- FWCI
- 38.59
- Percentile
- 100%
- References
- 34
Citations per year
Authors
5- CJClifford J. BaileyCorresponding
Aston University
- JLJorge Luiz Gross
Universidade Federal do Rio Grande do Sul
- APAnne Pieters
Bristol-Myers Squibb (Belgium)
- ABArnaud Bastien
Bristol-Myers Squibb (United States), Bristol-Myers Squibb (Germany)
- JFJames F. List
Bristol-Myers Squibb (Germany), Bristol-Myers Squibb (United States)
Topics & keywords
Topics
Keywords
- Dapagliflozin
- Metformin
- Medicine
- Placebo
- Type 2 diabetes
- Clinical endpoint
- Internal medicine
- Diabetes mellitus
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.